Contribution of NDM and OXA-type carbapenemases to carbapenem resistance in clinical Acinetobacter baumannii from Nigeria

References

• Eveillard M, Soltner C, Kempf M, et al. The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia. J Infect. 2010;60(2):154–161.
   PubMed Web of Science ®Google Scholar
• Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5(12):939–951.
   PubMed Web of Science ®Google Scholar
• Peleg A, Seifert H, Paterson D. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–582.
   PubMed Web of Science ®Google Scholar
• Muntasir IO, Samia AG, Abdullatif AH, et al. Prevalence and resistance profile of Acinetobacter baumannii clinical isolates from a private hospital in Khartoum Sudan. Am J Microbiol Res. 2015;3(2):76–79.
   Google Scholar
• Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197(8):1079–1081.
   PubMed Web of Science ®Google Scholar
• Livermore D, Woodford N. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 2006;14(9):413–419.
   PubMed Web of Science ®Google Scholar
• Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006;12(9):826–836.
   PubMed Web of Science ®Google Scholar
• Perez F, Hujer AM, Hujer KM, et al. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(10):3471–3484.
   PubMed Web of Science ®Google Scholar
• Helal S, El Anany M, Ghaith D, et al. The role of MDR-Acinetobacter baumannii in orthopedic surgical site infections. Surg Infect. 2015;16(5):518–522.
   PubMed Web of Science ®Google Scholar
• Hasanin A, Mukhtar A, El-Adawy A, et al. Ventilator associated pneumonia caused by extensive-drug resistant Acinetobacter species: colistin is the remaining choice. Egypt J Anaesth. 2016;32(3):409–413.
   Web of Science ®Google Scholar
• Poirel L, Marque S, Heritier C, et al. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2005;49(1):202–208.
   PubMed Web of Science ®Google Scholar
• Higgins PG, Dammhayn C, Hackel M, et al. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2010;65(2):233–238.
   PubMed Web of Science ®Google Scholar
• Zarrilli R, Pournaras S, Giannouli M, et al. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents. 2013;41(1):11–19.,
   PubMed Web of Science ®Google Scholar
• Robledo IE, Aquino EE, Santé MI, et al. Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother. 2010;54(3):1354–1357.
   PubMed Web of Science ®Google Scholar
• Bonnin RA, Nordmann P, Potron A, et al. Carbapenem-hydrolyzing GES-type extended-spectrum beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother. 2011;55(1):349–354.
   PubMed Web of Science ®Google Scholar
• Zeka AN, Poirel L, Sipahi OR, et al. GES-type and OXA-23 carbapenemase-producing Acinetobacter baumannii in Turkey. J Antimicrob Chemother. 2013;69(4):1145–1146.
   PubMed Web of Science ®Google Scholar
• Olaitan AO, Berrazeg M, Fagade OE, et al. Emergence of multidrug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase, Nigeria. Int J Infect Dis. 2013;17(6):e469–e470.
   PubMed Web of Science ®Google Scholar
• Ogbolu DO, Daini OA, Ogunledun A, et al. High levels of multidrug resistance in clinical isolates of Gram-negative pathogens from Nigeria. Int J Antimicrob Agents. 2011;37(1):62–66.
   PubMed Web of Science ®Google Scholar
• Ogbolu DO, Webber MA. High-level and novel mechanisms of carbapenem resistance in Gram-negative bacteria from tertiary hospitals in Nigeria. Int J Antimicrob Agents. 2014;43(5):412–417.
   PubMed Web of Science ®Google Scholar
• Alli OAT, Ogbolu DO, Mustapha J, et al. The non-association of PVL and mecA genes on the genome of Staphylococcus aureus from hospitals in South Western Nigeria. Indian J Med Microbiol. 2012;30(2):159–164.
   PubMed Web of Science ®Google Scholar
• CLSI. Performance standards for antimicrobial disk susceptibility tests. CLSI standard M02. 13th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
   Google Scholar
• Bogaerts P, Rezende de Castro R, Roisin S, et al. Emergence of NDM-1-producing Acinetobacter baumannii in Belgium. J Antimicrob Chemother. 2012;67(6):1552–1553.
   PubMed Web of Science ®Google Scholar
• Berrazeg M, Diene S, Medjahed L, et al. New Delhi metallo-beta-lactamase around the world: an eReview using Google Maps. Eurosurveillance. 2014;19(20):pii 20809.
   Web of Science ®Google Scholar
• Handal R, Qunibi L, Sahouri I, et al. Characterization of carbapenem-resistant Acinetobacter baumannii strains isolated from hospitalized patients in Palestine. Int J Microbiol. 2017;2017:8012104–8012107.
   PubMed Web of Science ®Google Scholar
• Zarrilli R, Giannouli M, Tomasone F, et al. Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities. J Infect Dev Ctries. 2009;3(5):335–341.
   PubMed Web of Science ®Google Scholar
• Woodford N, Ellington MJ, Coelho JM, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006;27(4):351–353.
   PubMed Web of Science ®Google Scholar
• Irfan S, Turton JF, Mehraj J, et al. Molecular and epidemiological characterisation of clinical isolates of carbapenem-resistant Acinetobacter baumannii from public and private sector intensive care units in Karachi, Pakistan. J Hosp Infect. 2011;78(2):143–148.
   PubMed Web of Science ®Google Scholar
• Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597–602.
   PubMed Web of Science ®Google Scholar
• Zmarlicka MT, Nailor MD, Nicolau DP. Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics. Infect Drug Resist. 2015;8:297–309.
   PubMed Web of Science ®Google Scholar
• Matsui M, Suzuki S, Yamane K, et al. Distribution of carbapenem resistance determinants among epidemic and non-epidemic types of Acinetobacter species in Japan. J Med Microbiol. 2014;63(6):870–877.
   PubMedGoogle Scholar
• Tada T, Miyoshi-Akiyama T, Shimada K, et al. Dissemination of clonal complex 2 Acinetobacter baumannii strains co-producing carbapenemases and 16S rRNA methylase ArmA in Vietnam. BMC Infect Dis. 2015;15:433.
   PubMed Web of Science ®Google Scholar